N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide
TL;DR: N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide (CAS 894036-66-9) is a chemical compound with molecular formula C17H14N6O2S and molecular weight 366.09 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-(5-methyl-1,2-oxazol-3-yl)-2-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulfanyl]acetamide
Also Known As: N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide, N-(5-methylisoxazol-3-yl)-2-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)thio)acetamide, N-(5-methyl-1,2-oxazol-3-yl)-2-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulfanyl]acetamide
| Molecular Formula | C17H14N6O2S |
|---|---|
| Molecular Weight | 366.09 g/mol |
| LogP | 2.81852 |
| Topological Polar Surface Area | 98.21 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Exact Mass | 366.0899 |
| Heavy Atoms | 26 |
| Complexity | 1059.5084 |
Chemical Identifiers
| CAS Number | 894036-66-9 |
|---|---|
| SMILES | CC1=CC(=NO1)NC(=O)CSC2=NN=C3N2N=C(C=C3)C4=CC=CC=C4 |
Product Overview
N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide (CAS 894036-66-9), with molecular formula C17H14N6O2S and molecular weight 366.09 g/mol. IUPAC: N-(5-methyl-1,2-oxazol-3-yl)-2-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulfanyl]acetamide.
Chemical Property Profile of N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide
Property Insights of N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide
The XLogP value of 2.81852 suggests moderate lipophilicity, balancing water solubility and membrane permeability for N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide. The TPSA of 98.21 Ų falls within the moderate polarity range, balancing permeability and solubility for N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide. Following Lipinski's Rule of Five, N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide has 1 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide?
The CAS number of N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide is 894036-66-9.
What is the molecular formula of N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide?
The molecular formula of N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide is C17H14N6O2S.
What is the molecular weight of N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide?
The molecular weight of N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide is 366.09 g/mol.
Where can I buy N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide?
You can request a quote for N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide?
Yes, KEHONG BIO provides custom synthesis services for N-(5-methyl-1,2-oxazol-3-yl)-2-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}sulfanyl)acetamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.